All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
An expert panel hosted by
Customizing first-line BTK inhibitors for CLL
with Gilles Salles, Paolo Ghia, and Francesc Bosch
Wednesday, October 23, 2024
18:30-19:30 BST
This independent educational activity is supported by Pharmacyclics LLC, an AbbVie Company and Janssen Biotech. All content is developed independently by the faculty. The funder is allowed no influence on the content of this activity.
The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Doctor Astrid Pavlovsky is the Medical Director of the Pavlovsky Center and staff member in the Hematology Department in FUNDALEU, Buenos Aires, AR. She is a specialist in internal medicine and hematology. Dr Pavlovsky graduated from medical school with honors at the Universidad del Salvador, AR, in 1997. She completed training in internal medicine at Hospital Italiano de Buenos Aires, AR, for five years and continued her training in FUNDALEU as a Fellow in Hematology in Buenos Aires, AR.
Dr Pavlovsky is actively involved in different clinical trials as Principal Investigator or Co-Investigator in lymphoproliferative diseases. She is currently the Principal Investigator in a clinical trial for Hodgkin lymphoma.
Positions of responsibility/awards: